The study was funded by the Alzheimer's Drug Discovery Foundation. Read More
Researchers at the University of Liverpool and Nagoya University uncovered new drug candidates with promising therapeutic potential. Read More
New research highlights the results of phase 1/2 clinical trial involving the experimental drug treatment tofersen. Read More
The study involved 161 people with ALS who were compared to 80 people who did not have the disease. Read More
